Hannah R. Murphy

Hannah R. Murphy

Auto-generated profile, based on publicly available information

Hannah R. Murphy

Center for Advanced Analytics & Informatics

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2023 in Environmental Research
Verified
Journal Article
Open access
ZRZorimar Rivera-Núñez
Zorimar Rivera-Núñez
CKCarolyn W. Kinkade
Carolyn W. Kinkade
LKLeena Khoury
Leena Khoury
JBJessica Brunner
Jessica Brunner
HMHannah Murphy
Hannah Murphy
EBEmily Barrett
Emily Barrett
Poly- and perfluoroalkyl substances (PFAS) are ubiquitous and persistent environmental contaminants that may act as endocrine disruptors in utero, but the specific endocrine pathways are unknown. We examined associations between maternal serum PFAS and sex steroid hormones at three time points during pregnancy. Pregnant women participating in the Understanding Pregnancy Signals and Infant Development (UPSIDE) study contributed biospecimens, questionnaire, and medical record data in each trimester (n = 285). PFAS (including perfluorooctanoic acid (PFOA), perfluorooctanesulfonic acid (PFOS), perfluorohexane sulfonic acid (PFHxS), perfluorononanoic acid (PFNA) and perfluorodecanoic acid (PFDA)) were analyzed in second-trimester serum samples by high-performance liquid chromatography and tandem mass spectrometry (LC-MS/MS). Total testosterone [TT], free testosterone [fT], estrone [E1], estradiol [E2], and estriol [E3]) were measured by LC-MS/MS in serum samples from each trimester. Linear mixed models with random intercepts were used to examine associations between log-transformed PFAS concentrations and hormone levels, adjusting for covariates, and stratifying by fetal sex. Results are presented as the mean percentage difference (Δ%) in hormone levels per ln-unit increase in PFAS concentration. In adjusted models, PFHxS was associated with higher TT (%Δ = 20.0, 95%CI: 1.7, 41.6), particularly among women carrying male fetuses (%Δ = 15.3, 95%CI: 1.2, 30.7); this association strengthened as the pregnancy progressed. PFNA (%Δ = 7.9, 95%CI: 3.4, 12.5) and PFDA (%Δ = 7.2, 95%CI: 4.9, 9.7) were associated with higher fT, with associations again observed only in women carrying male fetuses. PFHxS was associated with higher levels of E2 and E3 in women carrying female fetuses (%Δ = 13.2, 95%CI: 0.5, 29.1; %Δ = 17.9, 95%CI: 3.2, 34.8, respectively). No associations were observed for PFOS and PFOA. PFHxS, PFNA, and PFDA may disrupt androgenic and estrogenic pathways in pregnancy in a sex-dependent manner.

23 November 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
TDTimothy Dye
Timothy Dye
MBMonica Barbosu
Monica Barbosu
SSShazia Siddiqi
Shazia Siddiqi
JRJose G Perez Ramos
Jose G Perez Ramos
HMHannah Murphy
Hannah Murphy
EPEva K. Pressman
Eva K. Pressman
Background: Determinants of COVID-19 vaccine acceptance are complex; how perceptions of the effectiveness of science, healthcare and government impact personal COVID-19 vaccine acceptance is unclear, despite all three domains providing critical roles in development, funding and provision, and distribution of COVID-19 vaccine. Objective: To estimate impact of perception of science, healthcare systems, and government along with sociodemographic, psychosocial, and cultural characteristics on vaccine acceptance. Design: We conducted a global nested analytical cross-sectional study of how the perceptions of healthcare, government and science systems have impacted COVID-19 on vaccine acceptance. Setting: Global Facebook, Instagram and Amazon Mechanical Turk (mTurk) users from 173 countries. Participants: 7411 people aged 18 years or over, and able to read English, Spanish, Italian, or French. Measurements: We used Χ 2 analysis and logistic regression-derived adjusted Odds Ratios (aORs) and 95% CIs to evaluate the relationship between effectiveness perceptions and vaccine acceptance controlling for other factors. We used natural language processing and thematic analysis to analyse the role of vaccine-related narratives in open-ended explanations of effectiveness. Results: After controlling for confounding, attitude toward science was a strong predictor of vaccine acceptance, more so than other attitudes, demographic, psychosocial or COVID-19-related variables (aOR: 2.1; 95% CI: 1.8 to 2.5). The rationale for science effectiveness was dominated by vaccine narratives, which were uncommon in other domains. Limitations: This study did not include participants from countries where Facebook and Amazon mTurk are not available, and vaccine acceptance reflected intention rather than actual behaviour. Conclusions: As our findings show, vaccine-related issues dominate public perception of science’s impact around COVID-19, and this perception of science relates strongly to the decision to obtain vaccination once available.

17 May 2023 in Psychosomatic Medicine
Verified
Journal Article
Closed access
LPLisa S. PhD Panisch
Lisa S. PhD Panisch
HMHannah R. Murphy
Hannah R. Murphy
QWQiuyi Bs Wu
Qiuyi Bs Wu
JBJessica L. Bs Brunner
Jessica L. Bs Brunner
ZDZoe T. Ba Duberstein
Zoe T. Ba Duberstein
TOThomas G. O’cOnnor
Thomas G. O’cOnnor
Objective: Adverse childhood experiences (ACEs) are associated with negative prenatal and perinatal health outcomes and may, via these pathways, have intergenerational effects on child health and development. We examine the impact of ACEs on maternal salivary cortisol, a key measure of prenatal biology previously linked with pregnancy-related health outcomes. Methods: Leveraging assessments across three trimesters, we used linear mixed-effects models to analyze the influence of ACEs on maternal prenatal diurnal cortisol patterns in a diverse cohort of pregnant women (analytic sample, n = 207). Covariates included comorbid prenatal depression, psychiatric medications, and sociodemographic factors. Results: Maternal ACEs were significantly associated with flatter diurnal cortisol slopes (i.e., less steep decline), after adjusting for covariates, with effects consistent across gestation (estimate = 0.15, standard error = 0.06, p = .008). Conclusions: ACEs experienced before pregnancy may have a robust and lasting influence on maternal prenatal hypothalamic-pituitary-adrenal activity throughout gestation, a key biological marker associated with perinatal and child health outcomes. The findings suggest one route of intergenerational transmission of early adverse experiences and underscore the potential value of assessing prepregnancy adverse experiences for promoting perinatal and maternal and child health.

17 March 2025 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
YMYing Meng
Ying Meng
LTLoralei L. Thornburg
Loralei L. Thornburg
CDCaitlin Dreisbach
Caitlin Dreisbach
COCharlotte Orzolek
Charlotte Orzolek
AKAmber Kautz
Amber Kautz
EBEmily S. Barrett
Emily S. Barrett

1 June 2026 in Journal of Intensive Care Medicine
Verified
Journal Article
Open access
MGMaria Gabriela Gastanadui
Maria Gabriela Gastanadui
HMHannah R. Murphy
Hannah R. Murphy
ASAndi Shahu
Andi Shahu
IIIsrael Israel
Israel Israel
CHCory Heck
Cory Heck
EMElliott Miller
Elliott Miller
Background: The pathophysiology of CS is complex and is associated with increased inflammation and impaired vascular tone. Corticosteroids are recommended in septic shock and have been proposed as a potential treatment for other types of shock. Objectives: We sought to evaluate the clinical outcomes associated with early corticosteroid use in patients with cardiogenic shock (CS). Methods: Using a nationally representative database including over 1000 hospitals, we identified adults ≥18 years of age admitted from 2015–2023 with a diagnosis of CS. Patients with adrenal insufficiency, chronic rheumatologic conditions, COVID-19 infection and acute COPD exacerbation were excluded. Using inverse probability treatment weighting (IPTW), we assessed for the association of receiving early corticosteroids (within the first 2 days of admission) versus no early corticosteroids and in-hospital mortality. Results: Of the 167,721 identified patients with CS, the mean (SD) age was 65.5 (±15.2) years and 35.0% were women. A total of 13.2% received any corticosteroid within the first 2 days of admission. The most common corticosteroid was hydrocortisone (73.9%). Mortality for those receiving and not receiving early corticosteroids was 48.8% and 29.6% ( p < 0.001), respectively. After IPTW, early corticosteroid use remained associated with a 3.1% (95% confidence interval [CI]: 2.4% to 3.8%, p < 0.001) higher mortality. Among patients with CS and concomitant sepsis, 27.6% received early corticosteroids, which was similarly associated with a higher mortality (weighted mean 5.8% [95% CI: 4.6% to 7.0%, p < 0.001]). Conclusions: Approximately 1 in 7 patients with CS received corticosteroids early during their admission, which was associated with higher in-hospital mortality.